681 related articles for article (PubMed ID: 27913996)
1. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
Ishioka M; Miura K; Minami S; Shimura Y; Ohnishi H
Dig Dis Sci; 2017 Feb; 62(2):396-406. PubMed ID: 27913996
[TBL] [Abstract][Full Text] [Related]
2. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
[TBL] [Abstract][Full Text] [Related]
3. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
[TBL] [Abstract][Full Text] [Related]
4. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.
Schneider KM; Mohs A; Kilic K; Candels LS; Elfers C; Bennek E; Schneider LB; Heymann F; Gassler N; Penders J; Trautwein C
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646522
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
[TBL] [Abstract][Full Text] [Related]
7. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota Plays Essential Roles in Soyasaponin's Preventive Bioactivities against Steatohepatitis in the Methionine and Choline Deficient (MCD) Diet-Induced Non-Alcoholic Steatohepatitis (NASH) Mice.
Su C; Wang J; Luo H; Chen J; Lin F; Mo J; Xiong F; Zha L
Mol Nutr Food Res; 2024 Feb; 68(4):e2300561. PubMed ID: 38234006
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
12. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
Pataky Z; Genton L; Spahr L; Lazarevic V; Terraz S; Gaïa N; Rubbia-Brandt L; Golay A; Schrenzel J; Pichard C
Dig Dis Sci; 2016 Sep; 61(9):2721-31. PubMed ID: 27142672
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes.
Suzuki-Kemuriyama N; Abe A; Nakane S; Yuki M; Miyajima K; Nakae D
PLoS One; 2023; 18(8):e0287657. PubMed ID: 37535625
[TBL] [Abstract][Full Text] [Related]
14. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
[TBL] [Abstract][Full Text] [Related]
15. Soyasaponin A
Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
[TBL] [Abstract][Full Text] [Related]
16. Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism.
Huang X; Chen Q; Fan Y; Yang R; Gong G; Yan C; Song Y; Zhang B; Xi S; Huang Y; Xu H
Biomed Pharmacother; 2023 Mar; 159():114300. PubMed ID: 36696803
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice.
Cao Y; Pan Q; Cai W; Shen F; Chen GY; Xu LM; Fan JG
Arch Iran Med; 2016 Mar; 19(3):197-203. PubMed ID: 26923892
[TBL] [Abstract][Full Text] [Related]
18. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
[TBL] [Abstract][Full Text] [Related]
19. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
20. Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.
Reid DT; McDonald B; Khalid T; Vo T; Schenck LP; Surette MG; Beck PL; Reimer RA; Probert CS; Rioux KP; Eksteen B
Biochim Biophys Acta; 2016 Jul; 1862(7):1337-44. PubMed ID: 27085070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
